Kirn David
Transaction: 08/04/2026
SELL
Change
-26,842
Price
$10.23
Filing
08/05/2026
Type
SELL
4D Molecular Therapeutics, Inc.
FDMT • Biotechnology
$14.97
▲ +0.27 (+1.84%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.05B
Growth
18.0%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 22.6%Manageable debt level · 0.04Healthy liquidity · 9.39Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:11 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$14.97
Change1.84%
Shares Out70.27M
Market Cap$1.05B
Enterprise Value$710.27M
52W Range5.97 - 14.00
Beta2.69
P/E-5.87
P/S11.92
P/B2.58
P/FCF-6.71
EV/Sales8.05
Price$14.97
Change1.84%
Shares Out70.27M
Market Cap$1.05B
Enterprise Value$710.27M
52W Range5.97 - 14.00
Beta2.69
P/E-5.87
P/S11.92
P/B2.58
P/FCF-6.71
EV/Sales8.05
EV/EBITDA-3.80
EV/FCF-4.53
Earnings Yield-17.03%
FCF Yield-14.89%
Dividend Yield0.00%
Gross Margin91.05%
Oper. Margin-187.24%
Profit Margin-164.43%
Debt/Eq0.04
Current Ratio9.39
Quick Ratio9.39
Revenue 5Y18.04%
Target$32.00
Target Upside113.76%
Target Median$32.00
Target Range32.00 - 32.00
Volume694.53K
Avg Volume794.85K
EPS Surprise-0.04
Investment DNA
How strong this company looks for long-term investors
53
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
78/100
Why this score▼
Positive revenue growth · 22.6%Manageable debt level · 0.04Healthy liquidity · 9.39Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 14 analyst votes · 2026-09-05
82/100
Bullish
Bullish
10
Hold
3
Bearish
1
Price Target
2026-08-14
Low
$32.00
Mean
$32.00
Median
$32.00
High
$32.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Kirn David
Transaction: 08/03/2026
SELL
Change
-12,415
Price
$10.05
Filing
08/04/2026
Type
SELL
Kirn David
Transaction: 07/10/2026
SELL
Change
-442
Price
$12.84
Filing
07/14/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Kirn David | SELL | -26,842 | $10.23 | 08/04/2026 | 08/05/2026 |
| Kirn David | SELL | -12,415 | $10.05 | 08/03/2026 | 08/04/2026 |
| Kirn David | SELL | -442 | $12.84 | 07/10/2026 | 07/14/2026 |
| Kirn David | SELL | -42,608 | $12.87 | 07/09/2026 | 07/14/2026 |
| Bizily Scott | SELL | -6,566 | $14.00 | 06/30/2026 | 07/02/2026 |
| Bizily Scott | SELL | -5,752 | $6.49 | 06/30/2026 | 07/02/2026 |
| Bizily Scott | SELL | -9,810 | $12.00 | 06/23/2026 | 06/25/2026 |
| Bizily Scott | SELL | -9,810 | $4.14 | 06/23/2026 | 06/25/2026 |
| Kirn David | SELL | -114,746 | $10.47 | 06/22/2026 | 06/23/2026 |
| Chacko Jacob | BUY | +50,000 | $9.42 | 06/17/2026 | 06/18/2026 |
| SBLENDORIO GLENN | BUY | +50,000 | $9.42 | 06/17/2026 | 06/18/2026 |
| MILLIGAN JOHN F | BUY | +75,000 | $9.42 | 06/17/2026 | 06/18/2026 |
| GRAY SUSANNAH | BUY | +50,000 | $9.42 | 06/17/2026 | 06/18/2026 |
| Miller-Rich Nancy | BUY | +50,000 | $9.42 | 06/17/2026 | 06/18/2026 |
| THEUER CHARLES | BUY | +50,000 | $9.42 | 06/17/2026 | 06/18/2026 |
| Tomasello Shawn | BUY | +50,000 | $9.42 | 06/17/2026 | 06/18/2026 |
| Kirn David | SELL | -1,922 | $10.02 | 06/01/2026 | 06/02/2026 |
| Simms Christopher Paul | BUY | +219,000 | $9.88 | 03/25/2026 | 03/27/2026 |
| Bizily Scott | BUY | +217,000 | $9.88 | 03/25/2026 | 03/27/2026 |
| Kirn David | BUY | +750,000 | $9.88 | 03/25/2026 | 03/27/2026 |